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Trichloroethylene is commonly used as an industrial solvent and degreasing agent. 
The clinical features of acute and chronic intoxication with trichloroethylene are 
well-known and have been described in many reports, but hypersensitivity syn-
drome caused by trichloroethylene is rarely encountered. For managing patients 
with trichloroethylene hypersensitivity syndrome, avoiding trichloroethylene and 
initiating glucocorticoid have been generally accepted. Generally, glucocorticoid 
had been tapered as trichloroethylene hypersensitivity syndrome had ameliorated. 
However, we encountered a typical case of trichloroethylene hypersensitivity syn-
drome refractory to high dose glucocorticoid treatment. A 54-year-old Korean man 
developed jaundice, fever, red sore eyes, and generalized erythematous maculo-
papular rashes. A detailed history revealed occupational exposure to trichloroethyl-
ene. After starting intravenous methylprednisolone, his clinical condition im-
proved remarkably, but we could not reduce prednisolone because his liver enzyme 
and total bilirubin began to rise within 2 days after reducing prednisolone under 60 
mg/day. We recommended an extended admission for complete recovery, but the 
patient decided to leave the hospital against medical advice. The patient visited the 
emergency department due to pneumonia and developed asystole, which did not 
respond to resuscitation. 
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INTRODUCTION
Trichloroethylene (TCE) is a volatile chlorinated organic compound commonly 
used in industrial settings as a degreaser for metal parts and as a general-purpose 
solvent for lipophilic compounds. It is most commonly used in electronics, print-
ing, electroplating, and hardware companies. Idiosyncratic generalized skin disor-
ders complicated by hepatitis caused by exposure to TCE, which is similar to seri-
ous drug hypersensitivity, have been reported.1 Goon, et al.2 suggested the name 
TCE hypersensitivity syndrome to describe a syndrome consisting of exfoliative 
dermatitis, mucous membrane erosion, eosinophilia, and hepatitis after exposure 
to TCE.3-6 An epidemiologic study proved that TCE could be a cause of hypersen-Hyun Gul Jung, et al.
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confluent and dusky (Fig. 1). No blisters were seen at pre-
sentation. There were moist erosions on the patient’s lips, 
buccal mucosa, and oropharynx. Bilateral conjunctival in-
jection was also noticed. Laboratory data were notable for 
the following; hemoglobin, 13.5 g/dL; white blood cell 
count, 8,630/mm3 with 0.11 eosinophils; C-reactive protein, 
4.1 mg/dL; erythrocyte sedimentation rate, 4.0 mm/hr; as-
partate aminotransferase (AST), 318 IU/L; alanine trans-
aminase (ALT), 650 IU/L; prothrombin time (PT), 57%; to-
tal bilirubin, 8.4 mg/dL; albumin, 3.1 g/dL, and creatinine, 
0.8 mg/dL. Laboratory tests were negative for hepatitis A, 
B, and C. Histologic examination of the patient’s skin showed 
subepidermal clefting and bulla formation, with necrotic 
keratinocytes in the middle and lower epidermis. Vacuolar 
degeneration in the basal layer, and infiltration of lympho-
cytes in the upper dermis and perivascular area were also 
observed (Fig. 2). Blood culture was negative. Repeated at-
tempts at questioning did not reveal any drug intake prior to 
the onset of symptoms but did elicit a history of occupa-
tional exposure to TCE. The patient had worked at a factory 
producing spoons for 1 month before developing symp-
toms. There were automated degreasing machines in the 
factory, and he had not been directly exposed to TCE. The 
urinary trichloroacetic acid level, measured by UV absorp-
tion method8 2 weeks after the patient’s last day at work, 
was 22 mg/L. Nobody shared similar symptoms with him 
in his workplace. A diagnosis of hypersensitivity syndrome 
caused by TCE was made. After initiating intravenous meth-
ylprednisolone (60 mg every 6 hours), a fever of 40.2°C 
started to subside, and the patient regained strength gradual-
ly. The AST, ALT, and total bilirubin levels had decreased 
to 67 IU/L, 167 IU/L, and 4.2 mg/dL, respectively, by the 
17th day.  However, we could not reduce prednisolone un-
der 60 mg/day because his liver enzyme and total bilirubin 
began to rise within 2 days after reducing prednisolone un-
der 60 mg/day. Although we strongly recommended longer 
admission, the patient decided to leave against medical ad-
vice and promised to revisit the out-patient clinics. We pre-
scribed prednisolone (60 mg once daily) and planned to fol-
low up within a week. Five days after discharge, the patient 
visited the emergency department due to dyspnea caused 
by left pneumonic infiltration with pleural effusion. Ac-
cording to his wife, he did not visit the factory again. Labo-
ratory data were notable for the following; hemoglobin, 9.0 
g/d; white blood cell count, 2,470/mm3; platelet count, 
135,000/mm3; AST, 36 IU/L; ALT, 38 IU/L; PT, 34%; and 
total bilirubin, 3.1 mg/dL. Blood culture yielded methicil-
sitivity skin disorder complicated by hepatitis.7 In order to 
manage patients, avoiding TCE, especially in workplace, 
should be recommended as the first step thereafter, gluco-
corticoid has been used for resolving skin disorders and 
hepatitis in this syndrome.2-6 Generally, glucocorticoid had 
been tapered as TCE hypersensitivity syndrome had im-
proved. However, we encountered a typical case of TCE 




A 54-year-old Korean man presented with jaundice that had 
developed 1 week earlier. He did not have any medical ill-
nesses. On presentation, his body temperature was 39.2°C, 
resting heart rate was 90 beats per minute, respiratory rate 
was 16 breaths per minute, and blood pressure was 125/80 
mm Hg. Physical examination revealed a generalized ery-
thematous maculopapular rash, which gradually became 
Fig. 1. Generalized maculopapular skin eruption with exfoliation is ob-
served.
Fig. 2. Histologic examination of the patient’s skin showed subepidermal 
clefting and bulla formation, with necrotic keratinocytes in the middle and 
lower epidermis. Vacuolar degeneration was evident in the basal layer, and 
there was an infiltrate of lymphocytes in the upper dermis and perivascular 
area (hematoxylin and eosin staining, ×100).Trichloroethylene Hypersensitivity Syndrome
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dose steroid was presumed to predispose pneumonia. 
In differentiating hypersensitivity syndrome from a toxic 
reaction, it is important to note that a toxic reaction will oc-
cur in most individuals at a given threshold dose, whereas 
hypersensitivity may occur at a very low dose.2 Our pa-
tient’s urinary TCE level was not excessive. However, it 
could not be an indicator of TCE hypersensitivity syndrome 
in our case because urinary TCE level was measured 2 
weeks after exposure.
Since only limited information is available regarding ex-
posure history of patients with TCE hypersensitivity syn-
drome, it can be a matter of debate whether TCE itself is a 
cause of hypersensitivity syndrome or not. One epidemio-
logic study tried to establish the three bases for TCE hyper-
sensitivity syndrome.7 First, TCE was detected in all of the 
available urine of the patients who participated in that study. 
Next, the role of exposures other than TCE, i.e. medications, 
solvent contaminants, stabilizers, and metals, in the develop-
ment of the skin disorders, was ruled out. Third, TCE induc-
es delayed-type hypersensitivity skin reactions and immune-
mediated liver injury in guinea pig maximization tests at 
doses below those inducing acute toxic liver injury.10 
Some researchers have explored the mechanism of TCE 
hypersensitivity syndrome in recent years. TCE hypersensi-
tive syndrome could be associated with the factors such as 
TNFα gene polymorphism, P450 metabolism enzyme gene 
expression, and enzyme gene polymorphism of aldehyde 
dehydrogenase and alcohol dehydrogenase.11 The allele 
HLAB*1301 was revealed to be associate with the risk of 
the disease among exposed workers and might be used as a 
biomarker to predict high risk individuals to TCE.12 Ac-
cording to two reports, human herpesvirus 6 was reactivat-
ed in patients suffering from TCE-induced hypersensitivity 
dermatitis.13,14 Since the finding was analogous with that 
observed in severe drug hypersensitivity, it demonstrated 
the possible involvement of human herpesvirus 6 in TCE 
hypersensitivity syndrome. However, the exact mechanism 
remains unclear. 
With regard to hepatitis, one study reported that 94% of 
patients of the TCE-related generalized skin disorders in 
China had suffered from hepatitis.15 This kind of idiosyn-
cratic hepatitis can be caused by other organic solvents, N, 
N-dimethylformamide and dimethylacetamide.16 The mech-
anism of hepatitis associated with TCE hypersensitivity syn-
drome may be similar to halothane hepatitis.17 Like halo-
thane, TCE is a two carbon poly-halogenated hydrocarbon. 
Several evidences suggested that hepatic injury by halo-
lin-sensitive Staphylococcus aureus. He was transferred to 
the medical intensive care unit but developed bradycardia 
and asystole, which did not respond to resuscitation, 6 hours 
after visiting emergency room. 
DISCUSSION
TCE can be absorbed via cutaneous, digestive and respira-
tory routes. Most absorbed TCE metabolizes to trichloro-
ethanol and trichloroacetic acid and is eliminated by the 
kidneys. Its half-life is about four days. Exposure to TCE 
vapor is the most frequent form of occupational exposure. 
It is readily inhaled, and 70% of inhaled vapor is absorbed 
systemically.2 In contrast to systemic TCE toxicity, there 
have been several cases of apparent TCE hypersensitivity 
syndrome, as named by Goon, et al.2-6,9 
According to Goon, et al.’s2 definition of TCE hypersensi-
tivity syndrome, which includes exfoliative dermatitis, mu-
cous membrane erosions, eosinophilia, and hepatitis after 
exposure to TCE, our case was definitely diagnosed as TCE 
hypersensitivity syndrome. There have been 4 cases that 
meet the criteria of TCE hypersensitivity syndrome in Ko-
rea.3-6 In 1999, a 20-year-old male began to work at jewelry 
industry was reported to have TCE hypersensitivity syn-
drome.3 After two weeks of avoidance of TCE exposure, he 
recovered from TCE hypersensitivity syndrome slowly. An-
other case was a 28-year-old male who degreased copper 
pipes with TCE about 13 hour per week. Twenty-seven days 
after beginning work, he showed the typical symptoms. 
Histopathological findings demonstrated spongiosis of epi-
dermis with lymphocyte infiltration. Skin patch test was 
positive for 0.25% or more TCE in olive oil.4 Third case was 
a 38-year-old man engaged in cleaning machine parts with 
TCE. After treatment with systemic corticosteroids, liver 
function and skin lesions were improved remarkably.5 The 
most recent case report in Korea was a 20-year-old man en-
gaged in silicon water proofing work with TCE. After treat-
ment with systemic corticosteroids, liver function and skin 
lesions were improved remarkably.6 All 5 patients, including 
our case, showed mucocutaneous lesions with hepatotoxicity 
and worked in factories using TCE: jewelry, silicon water 
proof, cleansing machine parts, degreasing copper pipes, and 
degreasing spoons.3-6 However, contrasting to our patient, 4 
patients recovered from TCE hypersensitivity without seri-
ous complications. Our patient symptoms and hepatitis were 
only responded high dose steroid treatment, and this high Hyun Gul Jung, et al.
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thane may be mediated by an antibody formed to trifluoro-
acetylated proteins which cross react with hepatic cellular 
component.18-20 The uniqueness of individuals with TCE 
hypersensitivity syndrome associated hepatitis either in 
their metabolism of TCE or in their failure to prevent the 
formation of an antibody which cross reacts with native he-
patic elements.17
Mortality from TCE hypersensitivity syndrome has been 
reported to be about 20% or even higher in China; liver fail-
ure, infection, and resulting sepsis were the principal causes 
of mortality.11 Several patients with TCE hypersensitivity 
syndrome died from serious liver dysfunction or from gas-
trointestinal bleeding and resulting disseminated intravas-
cular coagulation. Our patient also died due to sepsis from 
pneumonia; high dose steroid medication for TCE hyper-
sensitivity syndrome might contribute to the development 
of pneumonia.2,11 During hospitalization, we tried to reduce 
prednisolone dose for preventing infection and discharge 
planning. However, when we reduced prednisolone under 
60 mg once daily, his liver enzyme began to rise within 2 
days. Therefore, we initially opposed his discharge and fi-
nally planned to prescribe prednisolone 60 mg once daily 
with slow tapering plan based on out-patient follow up. High 
dose steroid treatment was presumed to be responsible for 
our patient’s death. However, TCE hypersensitivity that 
only responded to high dose steroid treatment was thought 
to be the initial cause of death in our case.
Because of its rarity, a physician may overlook the worse 
prognosis of the disease and may not give patients a strong 
enough warning of potential serious outcome. If our patient 
had not left the hospital, he might have recovered from this 
disorder completely. From this experience, we learned that, 
when TCE hypersensitivity is suspected, patients should be 
hospitalized until complete recovery is acquired to prevent 
grave outcomes caused by community-acquired infections. 
Moreover, we think that close official monitoring and ob-
servation will be effective to workers who start to deal with 
this solvent because TCE hypersensitivity syndrome occurs 
very quickly after exposure, averagely in 4 weeks.
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